New Alzheimer's Drug Targets Tau
This is a news story, published by ScienceDaily, that relates primarily to the University of Gothenburg news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
nerve cell protein tau. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest tau pathology news, Alzheimer news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
protein tauScienceDaily
•Health
Health
Opening for a new type of drug for Alzheimer's disease

78% Informative
A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.
This is the finding of research from the University of Gothenburg , which also offers a better way to measure the effect of treatment among patients.
The study provides insights into what happens during the earliest phase when the protein is transformed into thread-like strands in the nerve cells.
VR Score
85
Informative language
88
Neutral language
84
Article tone
formal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links